Human Pathology
Volume 41, Issue 5 , Pages 663-671 , May 2010

Pleomorphic and dedifferentiated leiomyosarcoma: clinicopathologic and immunohistochemical study of 41 cases

  • Marlo M. Nicolas, MD

      Affiliations

    • Department of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA
    • ,
  • Pheroze Tamboli, MD

      Affiliations

    • Department of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA
    • ,
  • Jose A. Gomez, MD

      Affiliations

    • Department of Pathology, London Health Sciences Centre, University Hospital, London, ON N6A 5A5, Canada
    • ,
  • Bogdan A. Czerniak, MD, PhD

      Affiliations

    • Department of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA
    • Corresponding Author InformationCorresponding author.

Received 14 May 2009 ,Revised 1 October 2009 ,Accepted 8 October 2009.

References 

  1. Oda Y, Miyajima K, Kawaguchi K, et al. Pleomorphic leiomyosarcoma: clinicopathologic and immunohistochemical study with special emphasis on its distinction from ordinary leiomyosarcoma and malignant fibrous histiocytoma. Am J Surg Pathol. 2001;25:1030–1038
  2. Fletcher CDM, van den Berg E, Molenaar WM. Pleomorphic malignant fibrous histiocytoma/undifferentiated high grade pleomorphic sarcoma. In:  Fletcher CDM,  Unni K,  Mertens F editor. World Health Organization Classification of Tumors. Pathology and genetics of tumors of soft tissue and bone. Lyon: IARC Press; 2002;p. 120–121
  3. Fletcher CDM. Giant cell malignant fibrous histiocytoma/unclassified pleomorphic sarcoma with giant cells. In:  Fletcher CDM,  Unni K,  Mertens F editor. World Health Organization Classification of Tumors. Pathology and genetics of tumors of soft tissue and bone. Lyon: IARC Press; 2002;p. 123–124
  4. Evans HL, Shipley J. Leiomyosarcoma. In:  Fletcher CDM,  Unni K,  Mertens F editor. World Health Organization Classification of Tumors. Pathology and genetics of tumors of soft tissue and bone. Lyon: IARC Press; 2002;p. 131–134
  5. Fletcher CD. Pleomorphic malignant fibrous histiocytoma: fact or fiction? A critical reappraisal based on 159 tumors diagnosed as pleomorphic sarcoma. Am J Surg Pathol. 1992;16:213–228
  6. Fletcher CD, Gustafson P, Rydholm A, et al. Clinicopathologic re-evaluation of 100 malignant fibrous histiocytomas: prognostic relevance of subclassification. J Clin Oncol. 2001;19:3045–3050
  7. Hashimoto H, Daimaru Y, Tsuneyoshi M, et al. Leiomyosarcoma of the external soft tissues. A clinicopathologic, immunohistochemical, and electron microscopic study. Cancer. 1986;57:2077–2088
  8. Hashimoto H, Daimaru Y, Tsuneyoshi M, et al. Soft tissue sarcoma with additional anaplastic components. A clinicopathologic and immunohistochemical study of 27 cases. Cancer. 1990;66:1578–1589
  9. Hilliard NJ, Heslin MJ, Castro CY. Leiomyosarcoma of the inferior vena cava: three case reports and review of the literature. Ann Diagn Pathol. 2005;9:259–266
  10. Candanedo-Gonzalez FA, Vela Chavez T, Cerbulo-Vazquez A. Pleomorphic leiomyosarcoma of the adrenal gland with osteoclast-like giant cells. Endocr Pathol. 2005;16:75–81
  11. Lujan MG, Hoang MP. Pleomorphic leiomyosarcoma of the adrenal gland. Arch Pathol Lab Med. 2003;127:e32–5
  12. Okuno T, Matsuda K, Ueyama K, et al. Leiomyosarcoma of the pulmonary vein. Pathol Int. 2000;50:839–846
  13. Grabellus F, Sheu SY, Schmidt B, et al. Recurrent high-grade leiomyosarcoma with heterologous osteosarcomatous differentiation. Virchows Arch. 2006;448:85–89
  14. Koh YS, Kim JC, Cho CK, et al. Pancreatic metastasis of leiomyosarcoma in the right thigh: a case report. World J Gastroenterol. 2007;13:1135–1137
  15. Sato N, Sato K, Matoba N, et al. Malignant mesenchymoma arising in an incisional scar of the abdominal wall. Eur J Surg Oncol. 1998;24:449–450
  16. Brooks JJ. The significance of double phenotypic patterns and markers in human sarcomas. A new model of mesenchymal differentiation. Am J Pathol. 1986;125:113–123
  17. Dahlin DC, Beabout JW. Dedifferentiation of low-grade chondrosarcomas. Cancer. 1971;28:461–466
  18. Evans HL. Liposarcoma: a study of 55 cases with a reassessment of its classification. Am J Surg Pathol. 1979;3:507–523
  19. Oshiro Y, Shiratsuchi H, Oda Y, et al. Rhabdoid features in leiomyosarcoma of soft tissue: with special reference to aggressive behavior. Mod Pathol. 2000;13:1211–1218
  20. Gaffney EF, Dervan PA, Fletcher CD. Pleomorphic rhabdomyosarcoma in adulthood. Analysis of 11 cases with definition of diagnostic criteria. Am J Surg Pathol. 1993;17:601–609
  21. Furlong MA, Mentzel T, Fanburg-Smith JC. Pleomorphic rhabdomyosarcoma in adults: a clinicopathologic study of 38 cases with emphasis on morphologic variants and recent skeletal muscle-specific markers. Mod Pathol. 2001;14:595–603
  22. Wile AG, Evans HL, Romsdahl MM. Leiomyosarcoma of soft tissue: a clinicopathologic study. Cancer. 1981;48:1022–1032
  23. Azumi N, Ben-Ezra J, Battifora H. Immunophenotypic diagnosis of leiomyosarcomas and rhabdomyosarcomas with monoclonal antibodies to muscle-specific actin and desmin in formalin-fixed tissue. Mod Pathol. 1988;1:469–474
  24. Perez-Montiel MD, Plaza JA, Dominguez-Malagon H, et al. Differential expression of smooth muscle myosin, smooth muscle actin, h-caldesmon, and calponin in the diagnosis of myofibroblastic and smooth muscle lesions of skin and soft tissue. Am J Dermatopathol. 2006;28:105–111
  25. Sakamoto A, Oda Y, Yamamoto H, et al. Calponin and h-caldesmon expression in atypical fibroxanthoma and superficial leiomyosarcoma. Virchows Arch. 2002;440:404–409
  26. Watanabe K, Kusakabe T, Hoshi N, et al. h-Caldesmon in leiomyosarcoma and tumors with smooth muscle cell-like differentiation: its specific expression in the smooth muscle cell tumor. Hum Pathol. 1999;30:392–396

PII: S0046-8177(09)00370-0

doi: 10.1016/j.humpath.2009.10.005

Human Pathology
Volume 41, Issue 5 , Pages 663-671 , May 2010

Article Tools

* Image Usage & Resolution